Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12610000181000
ACTRN12610000181000
Recruiting
Phase 3

In patients with paroxysmal lone atrial fibrillation can oral magnesium compared to placebo reduce the incidence of atrial fibrillation?

euroscience Department, Barwon Health0 sites200 target enrollmentMarch 1, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsparoxysmal lone atrial fibrillationCardiovascular - Coronary heart disease

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
paroxysmal lone atrial fibrillation
Sponsor
euroscience Department, Barwon Health
Enrollment
200
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
euroscience Department, Barwon Health

Eligibility Criteria

Inclusion Criteria

  • •Patients with paroxysmal lone atrial fibrillation documented by an electrical tracing (minimum of 2 episodes within prior 12 months)

Exclusion Criteria

  • •1\.Renal Failure with a serum urea \> 10 mmol/L.
  • •2\.Untreated hyperthyroidism.
  • •3\.Atrial fibrillation with associated cardiac disease with an abnormal transthoracic echocardiogram; e.g. cardiomyopathy, enlarged left atrium, valvular heart disease.
  • •4\.Symptomatic Inflammatory Bowel disease.
  • •5\.Currently taking Magnesium supplementation.
  • •6\.Daily consumption of alcohol \>4 standard drinks.
  • •7\.Transient paroxysmal atrial fibrillation secondary to other reversible disorders (e.g., thyrotoxicosis, cardiac or thoracic surgery, pneumonia, severe anemia)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Cryoballoon ablation compared with single ring radiofrequency ablation for the treatment of atrial fibrillation: The Hot and Cold StudyParoxysmal atrial fibrillationCardiovascular - Other cardiovascular diseases
ACTRN12615000967583Stuart Thomas220
Active, not recruiting
Not Applicable
Paroxysmal Atrial Fibrillation Ablation: complex fractionated atrial electrograms ablation in addition to pulmonary vein isolation versus pulmonary vein isolatioParoxysmal atrial fibrillationCardiovascular - Other cardiovascular diseasesSurgery - Surgical techniques
ACTRN12614001231639Massimiliano Faustino150
Recruiting
Phase 2
A single-center, prospective, randomized trial to evaluate the efficacy of ablation using the spatiotemporally distributed potentials visualized by a fractionation map compared with ablation using low-potential regions visualized by a voltage map in patients with recurrent sustained atrial fibrillation (ARCHERY trial).Recurrent Persistent Atrial Fibrillation
JPRN-jRCTs042230101aruse Yoshihisa30
Completed
Not Applicable
Atrial Fibrillation in Patients with an Implantable Cardiac Device during the COVID-19 PandemicAtrial fibrillationPermanent pacemakerImplantable cardioverter defibrillatorCardiovascular - Other cardiovascular diseases
ACTRN12620000692932The University of Adelaide10,346
Completed
Not Applicable
INDICO AF - Atrial Fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease.
NL-OMON55649Academisch Medisch Centrum50